REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,466 | -54.0% | 23,929 | +1.6% | 0.00% | -60.0% |
| Q2 2023 | $596,101 | -22.4% | 23,552 | -1.2% | 0.01% | -28.6% |
| Q1 2023 | $767,854 | +81.8% | 23,839 | +4.2% | 0.01% | +75.0% |
| Q4 2022 | $422,476 | -16.7% | 22,886 | +21.8% | 0.00% | -20.0% |
| Q3 2022 | $507,000 | +98.8% | 18,786 | +1.6% | 0.01% | +150.0% |
| Q2 2022 | $255,000 | -29.2% | 18,484 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $360,000 | +20.0% | 18,437 | +0.4% | 0.00% | +50.0% |
| Q4 2021 | $300,000 | -41.9% | 18,366 | -0.8% | 0.00% | -50.0% |
| Q3 2021 | $516,000 | -5.5% | 18,510 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $546,000 | +12.1% | 18,432 | +5.7% | 0.00% | 0.0% |
| Q1 2021 | $487,000 | -0.2% | 17,435 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $488,000 | +25.1% | 17,207 | +11.1% | 0.00% | 0.0% |
| Q3 2020 | $390,000 | +38.3% | 15,494 | +34.0% | 0.00% | 0.0% |
| Q2 2020 | $282,000 | +75.2% | 11,564 | +6.1% | 0.00% | +33.3% |
| Q1 2020 | $161,000 | – | 10,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |